More on ImClone's mystery bidder

The identity of ImClone's mystery bidder will be revealed tomorrow even if it does not make a final offer, the company said, as the Financial Times reported that the bidder was a U.S.-based drugmaker with "pipeline synergies" with its buyout target. Report | Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.